Search | DOGLALA

Komal Galande added blog News
2025-12-09 05:57:24 -

Can Personalized Cancer Vaccines Redefine Targeted Oncology Treatments?
"In-Depth Study on Executive Summary Personalized Cancer Vaccines Market Size and Share Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The world class...

0 Comments 0 Shares 906 Views

Please log in to like, share and comment!
Mahesh Chavan added blog News
2025-12-09 06:16:50 -

Oncology Companion Diagnostics Market to Reach USD 3.05 Billion by 2033, Driven by Personalized Cancer Treatments
Market Overview The global oncology companion diagnostics market size was valued at USD 1116.73 Million in 2024 and is projected to grow from USD 1248.51 Million in 2025 to reach USD 3047.37 Million by 2033, exhibiting a CAGR of 11.8% during the forecast period (2025–2033). The global Oncology Companion Diagnostics market is witnessing swift...

0 Comments 0 Shares 780 Views

Please log in to like, share and comment!
Rahul Rangwa added blog Other
2025-11-20 06:00:04 -

Spinal Cord Tumor Market Shows Steady Growth Fueled by Advancements in Oncology Treatments
"Executive Summary Spinal Cord Tumor Market: Growth Trends and Share Breakdown CAGR Value Global spinal cord tumor market size was valued at USD 482.71 million in 2024 and is projected to reach USD 686.47 million by 2032, with a CAGR of 4.5% during the forecast period of 2025 to 2032. Being a premium market research report, Spinal Cord Tumor Market report works as an innovative solution...

0 Comments 0 Shares 89 Views

Please log in to like, share and comment!
Komal Galande added blog Travel
2025-12-29 07:05:13 -

Is RNA Therapeutics Revolutionizing the Next Generation of Disease Treatment?
"Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA Therapeutics...

0 Comments 0 Shares 135 Views

Please log in to like, share and comment!